ID   KPCG_HUMAN              Reviewed;         697 AA.
AC   P05129; B7Z8Q0;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 3.
DT   15-MAR-2017, entry version 200.
DE   RecName: Full=Protein kinase C gamma type;
DE            Short=PKC-gamma;
DE            EC=2.7.11.13;
GN   Name=PRKCG; Synonyms=PKCG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Cui W.C., Yu L., Chu Y.Y., Wang J., Zheng L.H., Zhou G.J., Zhao S.Y.;
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-317 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=3755548; DOI=10.1126/science.3755548;
RA   Coussens L., Parker P.J., Rhee L., Yang-Feng T.L., Chen E.,
RA   Waterfield M.D., Francke U., Ullrich A.;
RT   "Multiple, distinct forms of bovine and human protein kinase C suggest
RT   diversity in cellular signaling pathways.";
RL   Science 233:859-866(1986).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 162-697 (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=8375396; DOI=10.1111/j.1432-1033.1993.tb18179.x;
RA   Kochs G., Hummel R., Meyer D., Hug H., Marme D., Sarre T.F.;
RT   "Activation and substrate specificity of the human protein kinase C
RT   alpha and zeta isoenzymes.";
RL   Eur. J. Biochem. 216:597-606(1993).
RN   [7]
RP   INTERACTION WITH CDCP1.
RX   PubMed=15851033; DOI=10.1016/j.cell.2005.02.019;
RA   Benes C.H., Wu N., Elia A.E.H., Dharia T., Cantley L.C., Soltoff S.P.;
RT   "The C2 domain of PKCdelta is a phosphotyrosine binding domain.";
RL   Cell 121:271-280(2005).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH TP53INP1 AND P53/TP53.
RX   PubMed=16377624; DOI=10.1074/jbc.M512074200;
RA   Yoshida K., Liu H., Miki Y.;
RT   "Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor
RT   suppressor in the apoptotic response to DNA damage.";
RL   J. Biol. Chem. 281:5734-5740(2006).
RN   [9]
RP   REVIEW ON FUNCTION.
RX   PubMed=12417016; DOI=10.1093/oxfordjournals.jbchem.a003274;
RA   Saito N., Shirai Y.;
RT   "Protein kinase C gamma (PKC gamma): function of neuron specific
RT   isotype.";
RL   J. Biochem. 132:683-687(2002).
RN   [10]
RP   REVIEW ON FUNCTION.
RX   PubMed=17629453; DOI=10.1016/j.cellsig.2007.05.014;
RA   Barnett M.E., Madgwick D.K., Takemoto D.J.;
RT   "Protein kinase C as a stress sensor.";
RL   Cell. Signal. 19:1820-1829(2007).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   UBIQUITINATION.
RX   PubMed=20596523; DOI=10.1371/journal.pone.0011332;
RA   Del Rincon S.V., Rogers J., Widschwendter M., Sun D., Sieburg H.B.,
RA   Spruck C.;
RT   "Development and validation of a method for profiling post-
RT   translational modification activities using protein microarrays.";
RL   PLoS ONE 5:E11332-E11332(2010).
RN   [13]
RP   STRUCTURE BY NMR OF 36-105.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the phorbol esters/diacylglycerol binding
RT   domain of protein kinase C gamma.";
RL   Submitted (DEC-2007) to the PDB data bank.
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 154-295 IN COMPLEX WITH
RP   CALCIUM IONS, AND COFACTOR.
RA   Pike A.C.W., Amos A., Johansson C., Sobott F., Savitsky P.,
RA   Berridge G., Fedorov O., Umeano C., Gorrec F., Bunkoczi G.,
RA   Debreczeni J., Von Delft F., Arrowsmith C.H., Edwards A., Weigelt J.,
RA   Sundstrom M., Knapp S.;
RT   "Crystal structure of C2 domain of protein kinase C gamma.";
RL   Submitted (APR-2007) to the PDB data bank.
RN   [15]
RP   VARIANTS CYS-141; GLN-415; ASP-523 AND SER-659.
RX   PubMed=9545390; DOI=10.1086/301819;
RA   Al-Maghtheh M., Vithana E.N., Inglehearn C.F., Moore T., Bird A.C.,
RA   Bhattacharya S.S.;
RT   "Segregation of a PRKCG mutation in two RP11 families.";
RL   Am. J. Hum. Genet. 62:1248-1252(1998).
RN   [16]
RP   SHOWS THAT THE VARIANTS ARE NOT A CAUSE OF RP11.
RX   PubMed=10441600; DOI=10.1086/302554;
RA   Dryja T.P., McEvoy J., McGee T.L., Berson E.L.;
RT   "No mutations in the coding region of the PRKCG gene in three families
RT   with retinitis pigmentosa linked to the RP11 locus on chromosome
RT   19q.";
RL   Am. J. Hum. Genet. 65:926-928(1999).
RN   [17]
RP   TISSUE SPECIFICITY, AND VARIANTS SCA14 TYR-101; PRO-119 AND ASP-128.
RX   PubMed=12644968; DOI=10.1086/373883;
RA   Chen D.-H., Brkanac Z., Verlinde C.L.M.J., Tan X.-J., Bylenok L.,
RA   Nochlin D., Matsushita M., Lipe H., Wolff J., Fernandez M.,
RA   Cimino P.J., Bird T.D., Raskind W.H.;
RT   "Missense mutations in the regulatory domain of PKC gamma: a new
RT   mechanism for dominant nonepisodic cerebellar ataxia.";
RL   Am. J. Hum. Genet. 72:839-849(2003).
CC   -!- FUNCTION: Calcium-activated, phospholipid- and diacylglycerol
CC       (DAG)-dependent serine/threonine-protein kinase that plays diverse
CC       roles in neuronal cells and eye tissues, such as regulation of the
CC       neuronal receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of
CC       receptors and neuronal functions related to sensitivity to
CC       opiates, pain and alcohol, mediation of synaptic function and cell
CC       survival after ischemia, and inhibition of gap junction activity
CC       after oxidative stress. Binds and phosphorylates GRIA4/GLUR4
CC       glutamate receptor and regulates its function by increasing plasma
CC       membrane-associated GRIA4 expression. In primary cerebellar
CC       neurons treated with the agonist 3,5-dihyidroxyphenylglycine,
CC       functions downstream of the metabotropic glutamate receptor
CC       GRM5/MGLUR5 and phosphorylates GRIN1/NMDAR1 receptor which plays a
CC       key role in synaptic plasticity, synaptogenesis, excitotoxicity,
CC       memory acquisition and learning. May be involved in the regulation
CC       of hippocampal long-term potentiation (LTP), but may be not
CC       necessary for the process of synaptic plasticity. May be involved
CC       in desensitization of mu-type opioid receptor-mediated G-protein
CC       activation in the spinal cord, and may be critical for the
CC       development and/or maintenance of morphine-induced reinforcing
CC       effects in the limbic forebrain. May modulate the functionality of
CC       mu-type-opioid receptors by participating in a signaling pathway
CC       which leads to the phosphorylation and degradation of opioid
CC       receptors. May also contributes to chronic morphine-induced
CC       changes in nociceptive processing. Plays a role in neuropathic
CC       pain mechanisms and contributes to the maintenance of the
CC       allodynia pain produced by peripheral inflammation. Plays an
CC       important role in initial sensitivity and tolerance to ethanol, by
CC       mediating the behavioral effects of ethanol as well as the effects
CC       of this drug on the GABA(A) receptors. During and after cerebral
CC       ischemia modulate neurotransmission and cell survival in synaptic
CC       membranes, and is involved in insulin-induced inhibition of
CC       necrosis, an important mechanism for minimizing ischemic injury.
CC       Required for the elimination of multiple climbing fibers during
CC       innervation of Purkinje cells in developing cerebellum. Is
CC       activated in lens epithelial cells upon hydrogen peroxide
CC       treatment, and phosphorylates connexin-43 (GJA1/CX43), resulting
CC       in disassembly of GJA1 gap junction plaques and inhibition of gap
CC       junction activity which could provide a protective effect against
CC       oxidative stress (By similarity). Phosphorylates p53/TP53 and
CC       promotes p53/TP53-dependent apoptosis in response to DNA damage.
CC       Involved in the phase resetting of the cerebral cortex circadian
CC       clock during temporally restricted feeding. Stabilizes the core
CC       clock component ARNTL/BMAL1 by interfering with its
CC       ubiquitination, thus suppressing its degradation, resulting in
CC       phase resetting of the cerebral cortex clock (By similarity).
CC       {ECO:0000250|UniProtKB:P63318, ECO:0000250|UniProtKB:P63319,
CC       ECO:0000269|PubMed:16377624}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|Ref.14};
CC       Note=Binds 3 Ca(2+) ions per subunit. The ions are bound to the C2
CC       domain. {ECO:0000269|Ref.14};
CC   -!- ENZYME REGULATION: Classical (or conventional) PKCs (PRKCA, PRKCB
CC       and PRKCG) are activated by calcium and diacylglycerol (DAG) in
CC       the presence of phosphatidylserine. Three specific sites; Thr-514
CC       (activation loop of the kinase domain), Thr-655 (turn motif) and
CC       Thr-674 (hydrophobic region), need to be phosphorylated for its
CC       full activation.
CC   -!- SUBUNIT: Interacts with GRIA4 (By similarity). Interacts with
CC       CDCP1. Interacts with TP53INP1 and p53/TP53. Interacts with
CC       ARNTL/BMAL1 (By similarity). {ECO:0000250|UniProtKB:P63318,
CC       ECO:0000269|PubMed:15851033, ECO:0000269|PubMed:16377624}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P63318}.
CC       Cytoplasm, perinuclear region {ECO:0000250}. Cell membrane
CC       {ECO:0000250|UniProtKB:P63318}; Peripheral membrane protein
CC       {ECO:0000250}. Cell junction, synapse, synaptosome
CC       {ECO:0000250|UniProtKB:P63318}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:P63319}. Note=Translocates to synaptic
CC       membranes on stimulation. {ECO:0000250|UniProtKB:P63318}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P05129-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05129-2; Sequence=VSP_056467, VSP_056468, VSP_056469;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in Purkinje cells of the cerebellar
CC       cortex. {ECO:0000269|PubMed:12644968}.
CC   -!- PTM: Autophosphorylation on Thr-674 appears to regulate motor
CC       functions of junctophilins, JPH3 and JPH4.
CC       {ECO:0000250|UniProtKB:P63318}.
CC   -!- PTM: Ubiquitinated. {ECO:0000269|PubMed:20596523}.
CC   -!- DISEASE: Spinocerebellar ataxia 14 (SCA14) [MIM:605361]:
CC       Spinocerebellar ataxia is a clinically and genetically
CC       heterogeneous group of cerebellar disorders. Patients show
CC       progressive incoordination of gait and often poor coordination of
CC       hands, speech and eye movements, due to degeneration of the
CC       cerebellum with variable involvement of the brainstem and spinal
CC       cord. SCA14 is an autosomal dominant cerebellar ataxia (ADCA).
CC       {ECO:0000269|PubMed:12644968}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Mutations of the PRKCG gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/prkcgmut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF345987; AAK13533.1; -; mRNA.
DR   EMBL; AK303741; BAH14036.1; -; mRNA.
DR   EMBL; AC008440; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC047876; AAH47876.1; -; mRNA.
DR   EMBL; M13977; AAA60102.1; -; mRNA.
DR   EMBL; Z15114; CAA78820.1; -; mRNA.
DR   CCDS; CCDS12867.1; -. [P05129-1]
DR   PIR; D24664; D24664.
DR   RefSeq; NP_001303258.1; NM_001316329.1.
DR   RefSeq; NP_002730.1; NM_002739.4. [P05129-1]
DR   UniGene; Hs.631564; -.
DR   PDB; 2E73; NMR; -; A=36-105.
DR   PDB; 2UZP; X-ray; 2.00 A; A/B/C=154-295.
DR   PDBsum; 2E73; -.
DR   PDBsum; 2UZP; -.
DR   ProteinModelPortal; P05129; -.
DR   SMR; P05129; -.
DR   BioGrid; 111568; 35.
DR   DIP; DIP-39795N; -.
DR   IntAct; P05129; 7.
DR   MINT; MINT-222801; -.
DR   STRING; 9606.ENSP00000263431; -.
DR   BindingDB; P05129; -.
DR   ChEMBL; CHEMBL2938; -.
DR   DrugBank; DB00675; Tamoxifen.
DR   GuidetoPHARMACOLOGY; 1484; -.
DR   iPTMnet; P05129; -.
DR   PhosphoSitePlus; P05129; -.
DR   SwissPalm; P05129; -.
DR   BioMuta; PRKCG; -.
DR   DMDM; 462455; -.
DR   EPD; P05129; -.
DR   MaxQB; P05129; -.
DR   PaxDb; P05129; -.
DR   PeptideAtlas; P05129; -.
DR   PRIDE; P05129; -.
DR   DNASU; 5582; -.
DR   Ensembl; ENST00000263431; ENSP00000263431; ENSG00000126583. [P05129-1]
DR   GeneID; 5582; -.
DR   KEGG; hsa:5582; -.
DR   UCSC; uc002qcq.2; human. [P05129-1]
DR   CTD; 5582; -.
DR   DisGeNET; 5582; -.
DR   GeneCards; PRKCG; -.
DR   GeneReviews; PRKCG; -.
DR   HGNC; HGNC:9402; PRKCG.
DR   HPA; CAB013051; -.
DR   HPA; HPA047870; -.
DR   HPA; HPA054560; -.
DR   MalaCards; PRKCG; -.
DR   MIM; 176980; gene.
DR   MIM; 605361; phenotype.
DR   neXtProt; NX_P05129; -.
DR   OpenTargets; ENSG00000126583; -.
DR   Orphanet; 98763; Spinocerebellar ataxia type 14.
DR   PharmGKB; PA33766; -.
DR   eggNOG; KOG0694; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00820000126964; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P05129; -.
DR   KO; K19663; -.
DR   OMA; RCFFGTS; -.
DR   OrthoDB; EOG091G0QRS; -.
DR   PhylomeDB; P05129; -.
DR   TreeFam; TF351133; -.
DR   BRENDA; 2.7.11.13; 2681.
DR   Reactome; R-HSA-111933; Calmodulin induced events.
DR   Reactome; R-HSA-114516; Disinhibition of SNARE formation.
DR   Reactome; R-HSA-416993; Trafficking of GluR2-containing AMPA receptors.
DR   Reactome; R-HSA-418597; G alpha (z) signalling events.
DR   Reactome; R-HSA-5099900; WNT5A-dependent internalization of FZD4.
DR   Reactome; R-HSA-76005; Response to elevated platelet cytosolic Ca2+.
DR   SignaLink; P05129; -.
DR   SIGNOR; P05129; -.
DR   EvolutionaryTrace; P05129; -.
DR   GeneWiki; PRKCG; -.
DR   GenomeRNAi; 5582; -.
DR   PMAP-CutDB; P05129; -.
DR   PRO; PR:P05129; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126583; -.
DR   CleanEx; HS_PRKCG; -.
DR   ExpressionAtlas; P05129; baseline and differential.
DR   Genevisible; P05129; HS.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0097060; C:synaptic membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004698; F:calcium-dependent protein kinase C activity; TAS:Reactome.
DR   GO; GO:0004672; F:protein kinase activity; IDA:HGNC.
DR   GO; GO:0004697; F:protein kinase C activity; TAS:ProtInc.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IDA:MGI.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007268; P:chemical synaptic transmission; IEA:Ensembl.
DR   GO; GO:0007635; P:chemosensory behavior; IEA:Ensembl.
DR   GO; GO:0060384; P:innervation; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:1901799; P:negative regulation of proteasomal protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; IDA:HGNC.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IDA:HGNC.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0016310; P:phosphorylation; IDA:HGNC.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0032425; P:positive regulation of mismatch repair; IDA:HGNC.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0050764; P:regulation of phagocytosis; IEA:Ensembl.
DR   GO; GO:0032095; P:regulation of response to food; ISS:UniProtKB.
DR   GO; GO:0043278; P:response to morphine; ISS:UniProtKB.
DR   GO; GO:0048265; P:response to pain; ISS:UniProtKB.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   CDD; cd00029; C1; 2.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR014375; Protein_kinase_C_a/b/g.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000550; PKC_alpha; 1.
DR   PRINTS; PR00360; C2DOMAIN.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Biological rhythms;
KW   Calcium; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Cytoplasm; Disease mutation; Kinase; Membrane;
KW   Metal-binding; Neurodegeneration; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Spinocerebellar ataxia; Synapse;
KW   Synaptosome; Transferase; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    697       Protein kinase C gamma type.
FT                                /FTId=PRO_0000055689.
FT   DOMAIN      170    260       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      351    614       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      615    685       AGC-kinase C-terminal.
FT   ZN_FING      35     85       Phorbol-ester/DAG-type 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   ZN_FING     100    150       Phorbol-ester/DAG-type 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   NP_BIND     357    365       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    480    480       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   METAL       186    186       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000269|Ref.14}.
FT   METAL       187    187       Calcium 1. {ECO:0000269|Ref.14}.
FT   METAL       187    187       Calcium 2. {ECO:0000269|Ref.14}.
FT   METAL       193    193       Calcium 2. {ECO:0000269|Ref.14}.
FT   METAL       246    246       Calcium 1. {ECO:0000269|Ref.14}.
FT   METAL       246    246       Calcium 2. {ECO:0000269|Ref.14}.
FT   METAL       247    247       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000269|Ref.14}.
FT   METAL       248    248       Calcium 1. {ECO:0000269|Ref.14}.
FT   METAL       248    248       Calcium 2. {ECO:0000269|Ref.14}.
FT   METAL       248    248       Calcium 3. {ECO:0000269|Ref.14}.
FT   METAL       251    251       Calcium 3. {ECO:0000269|Ref.14}.
FT   METAL       252    252       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000269|Ref.14}.
FT   METAL       254    254       Calcium 1. {ECO:0000269|Ref.14}.
FT   METAL       254    254       Calcium 3. {ECO:0000269|Ref.14}.
FT   BINDING     380    380       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     250    250       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     320    320       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63318}.
FT   MOD_RES     322    322       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63318}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63318}.
FT   MOD_RES     328    328       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63318}.
FT   MOD_RES     330    330       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63318}.
FT   MOD_RES     332    332       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P63318}.
FT   MOD_RES     373    373       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63318}.
FT   MOD_RES     514    514       Phosphothreonine; by PDPK1.
FT                                {ECO:0000250|UniProtKB:P63318}.
FT   MOD_RES     648    648       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     655    655       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:P63318}.
FT   MOD_RES     674    674       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:P63318}.
FT   MOD_RES     675    675       Phosphotyrosine; by SYK. {ECO:0000250}.
FT   MOD_RES     687    687       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63319}.
FT   VAR_SEQ       1     20       MAGLGPGVGDSEGGPRPLFC -> MPRICDLRVSRRWEGPP
FT                                DGR (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056467.
FT   VAR_SEQ      21    133       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056468.
FT   VAR_SEQ     553    588       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056469.
FT   VARIANT     101    101       H -> Y (in SCA14; dbSNP:rs121918511).
FT                                {ECO:0000269|PubMed:12644968}.
FT                                /FTId=VAR_017060.
FT   VARIANT     119    119       S -> P (in SCA14; dbSNP:rs121918512).
FT                                {ECO:0000269|PubMed:12644968}.
FT                                /FTId=VAR_017061.
FT   VARIANT     128    128       G -> D (in SCA14; dbSNP:rs121918513).
FT                                {ECO:0000269|PubMed:12644968}.
FT                                /FTId=VAR_017062.
FT   VARIANT     141    141       R -> C. {ECO:0000269|PubMed:9545390}.
FT                                /FTId=VAR_008755.
FT   VARIANT     415    415       H -> Q. {ECO:0000269|PubMed:9545390}.
FT                                /FTId=VAR_008756.
FT   VARIANT     523    523       A -> D. {ECO:0000269|PubMed:9545390}.
FT                                /FTId=VAR_008757.
FT   VARIANT     659    659       R -> S (in dbSNP:rs752933837).
FT                                {ECO:0000269|PubMed:9545390}.
FT                                /FTId=VAR_008758.
FT   CONFLICT    314    317       RVRM -> VSRT (in Ref. 5; AAA60102).
FT                                {ECO:0000305}.
FT   TURN         50     52       {ECO:0000244|PDB:2E73}.
FT   STRAND       57     59       {ECO:0000244|PDB:2E73}.
FT   TURN         67     69       {ECO:0000244|PDB:2E73}.
FT   HELIX        75     80       {ECO:0000244|PDB:2E73}.
FT   TURN         86     89       {ECO:0000244|PDB:2E73}.
FT   STRAND      160    169       {ECO:0000244|PDB:2UZP}.
FT   STRAND      172    182       {ECO:0000244|PDB:2UZP}.
FT   STRAND      194    201       {ECO:0000244|PDB:2UZP}.
FT   STRAND      222    230       {ECO:0000244|PDB:2UZP}.
FT   HELIX       233    237       {ECO:0000244|PDB:2UZP}.
FT   STRAND      239    246       {ECO:0000244|PDB:2UZP}.
FT   STRAND      249    251       {ECO:0000244|PDB:2UZP}.
FT   STRAND      254    262       {ECO:0000244|PDB:2UZP}.
FT   HELIX       263    268       {ECO:0000244|PDB:2UZP}.
FT   STRAND      271    276       {ECO:0000244|PDB:2UZP}.
FT   HELIX       280    283       {ECO:0000244|PDB:2UZP}.
SQ   SEQUENCE   697 AA;  78448 MW;  3F911B5BEF713C41 CRC64;
     MAGLGPGVGD SEGGPRPLFC RKGALRQKVV HEVKSHKFTA RFFKQPTFCS HCTDFIWGIG
     KQGLQCQVCS FVVHRRCHEF VTFECPGAGK GPQTDDPRNK HKFRLHSYSS PTFCDHCGSL
     LYGLVHQGMK CSCCEMNVHR RCVRSVPSLC GVDHTERRGR LQLEIRAPTA DEIHVTVGEA
     RNLIPMDPNG LSDPYVKLKL IPDPRNLTKQ KTRTVKATLN PVWNETFVFN LKPGDVERRL
     SVEVWDWDRT SRNDFMGAMS FGVSELLKAP VDGWYKLLNQ EEGEYYNVPV ADADNCSLLQ
     KFEACNYPLE LYERVRMGPS SSPIPSPSPS PTDPKRCFFG ASPGRLHISD FSFLMVLGKG
     SFGKVMLAER RGSDELYAIK ILKKDVIVQD DDVDCTLVEK RVLALGGRGP GGRPHFLTQL
     HSTFQTPDRL YFVMEYVTGG DLMYHIQQLG KFKEPHAAFY AAEIAIGLFF LHNQGIIYRD
     LKLDNVMLDA EGHIKITDFG MCKENVFPGT TTRTFCGTPD YIAPEIIAYQ PYGKSVDWWS
     FGVLLYEMLA GQPPFDGEDE EELFQAIMEQ TVTYPKSLSR EAVAICKGFL TKHPGKRLGS
     GPDGEPTIRA HGFFRWIDWE RLERLEIPPP FRPRPCGRSG ENFDKFFTRA APALTPPDRL
     VLASIDQADF QGFTYVNPDF VHPDARSPTS PVPVPVM
//
